Healthcare conglomerate specializing in pharmaceuticals, medical devices, and consumer health products with trusted global brands.
Profile & Fundamentals
Johnson & Johnson: Company identity, ownership, reported financial performance, balance sheets, and corporate actions.
Profile & Fundamentals
Johnson & Johnson Profile & Fundamentals
Examine company identity, ownership, reported performance, valuation, balance-sheet resilience, dividends, buybacks, and material corporate events.
Explore this pageJump to a Profile & Fundamentals section
Explore this research
Profile & Fundamentals contents
Jump directly to any section
Company and Market Context
Company Profile & Ownership
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Company profile record
Johnson & Johnson
Common Stock · Health Care · Pharmaceuticals
Company
- Company / asset
- Johnson & Johnson
- Security type
- Common Stock
- Sector
- Health Care
- Industry
- Pharmaceuticals
- HQ
- 🇺🇸 United States
- Head office
- One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933
Leadership & scale
- Chief executive
- Mr. Joaquin Duato
- CEO year born
- 1963
- Full-time employees
- 138.2K
- Fiscal year end
- December
- IPO date
- 1944-09-24
Fundamentals snapshot
- Market Cap
- USD 658.8B
- P/E
- 31.3x
- Revenue (Q2 26)
- USD 25.3B
- Profit (Q2 26)
- USD 5.5B
- Dividend Yield
- 1.4%
- Revenue (FY 25)
- USD 94.2B
- Shares in public float
- 2.4B
- Insider ownership
- 0.05%
Reporting & identifiers
- Symbol
- JNJ.NYSE
- Listing
- 🇺🇸 United States | Dividend Tax: 30%
- Ticker Currency
- USD
- Income Statement Currency
- USD
- Balance Sheet Currency
- USD
- Cash Flow Currency
- USD
- EPS Currency
- USD
- Contract Type
- SPOT
- ISIN
- US4781601046
- Asset ID
- equity_c3269539-01b8-5845-8971-363e7e618c20
Ownership
Shares Outstanding
- Shares outstanding
Top holders
- BlackRock Inc213,385,546 shares · 8.85% · Reported 2026-03-31
- Vanguard Capital Management, LLC156,605,370 shares · 6.50% · Reported 2026-03-31
- State Street Corp133,476,288 shares · 5.54% · Reported 2026-03-31
- Vanguard MStar Total Stk Mkt Idx Invest76,652,564 shares · 3.18% · Reported 2026-07-31
- Vanguard Portfolio Management, LLC63,514,436 shares · 2.64% · Reported 2026-03-31
- Vanguard 500 Index Investor63,192,258 shares · 2.62% · Reported 2026-07-31
- JPMorgan Chase & Co63,096,344 shares · 2.62% · Reported 2026-03-31
View more holders (8)
- Geode Capital Management, LLC59,164,862 shares · 2.46% · Reported 2026-03-31
- Morgan Stanley - Brokerage Accounts44,721,167 shares · 1.86% · Reported 2026-03-31
- iShares Core S&P 500 ETF32,055,505 shares · 1.33% · Reported 2026-08-31
- NORGES BANK31,825,084 shares · 1.32% · Reported 2026-06-30
- State Farm Mutual Automobile Ins Co31,590,952 shares · 1.31% · Reported 2026-06-30
- Fidelity 500 Index31,127,834 shares · 1.29% · Reported 2026-07-31
- State Street® SPDR® S&P 500® ETF29,507,724 shares · 1.22% · Reported 2026-08-31
- Northern Trust Corp29,319,669 shares · 1.22% · Reported 2026-03-31
Earnings, Profitability & Valuation
Earnings & Revenue
Revenue, Net Income, and Free Cash Flow
- Revenue
- Free cash flow
- Net income
Valuation
Historical P/E Ratio
- Published P/E
Profitability & Margins
Profitability Margins
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
Complete Research Workspace
Unlock the complete Profile & Fundamentals
Sign in to verify your access, or upgrade to the Base plan to open the complete profile & fundamentals and available source data.